January 17, 2023
The Network enhances its commitment to providing better care close to home, while practices gain resources to advance quality care and operational efficiency IRVING, Texas, Jan. 17, 2023 — The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, continues to expand its […]
Read MoreDecember 9, 2022
More than 40 investigators from the newly combined research network to present data from clinical trials focused on treating blood cancer and other blood disorders Nashville, Tenn. & The Woodlands, Texas (Dec. 9, 2022) – Sarah Cannon Research Institute (SCRI), US Oncology Research (USOR), and Ontada announced that collectively more than 65 affiliated abstracts and […]
Read MoreOctober 18, 2022
Speakers will focus on clinical, cost and access topics that create value in oncology IRVING, Texas, Oct. 18, 2022 — Thought leaders from McKesson will play a major role in the upcoming 2022 Association for Value-Based Cancer Care (AVBCC) Summit, speaking on a wide range of topics that showcase their extensive knowledge of the changing […]
Read MoreJune 6, 2022
Average monthly enrollment nearly doubled with pharmacy intervention Remote pharmacist easily adapted into clinic workflows in community practices THE WOODLANDS, TEXAS, June 6, 2022 — Results from the second phase of the broad, collaborative MYLUNG ConsortiumTM research study in non-small cell lung cancer (NSCLC) were presented by The US Oncology Network (The Network), US Oncology […]
Read MoreJune 3, 2022
Key research highlights include presentations on lung and ovarian cancers, value-based care, health technologies and health disparities THE WOODLANDS, Texas, June 3, 2022 — During the scientific program of the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, principal investigators from US Oncology Research, The US Oncology Network (The Network) and Ontada® will present detailed results from […]
Read MoreFebruary 8, 2022
Seven custom measures receive approval, raising the bar on oncology patient care IRVING, Texas, Feb. 8, 2022 — For the sixth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR). The designation enables iKnowMed℠ electronic health […]
Read MoreDecember 9, 2021
Highlights include clinical, real-world and health economic findings from studies of blood cancer treatments and hematological side effects in the community oncology setting THE WOODLANDS, Texas, Dec. 9, 2021 — Investigators from US Oncology Research, The US Oncology Network (The Network), and OntadaTM will share results from more than 30 studies exploring areas such as […]
Read MoreNovember 16, 2021
Practices using Oncology Care Model improved patient care while saving Medicare $197 million THE WOODLANDS, TEXAS, Nov. 16, 2021 — The Centers for Medicare & Medicaid Innovation (CMMI) recently released results for the 8th Performance Period (PP8) of the Oncology Care Model (OCM), and practices in The US Oncology Network (The Network) participating in the program […]
Read MoreSeptember 20, 2021
Successor will continue The Network’s success in supporting independent oncology practices nationwide THE WOODLANDS, TEXAS, Sept. 20, 2021 — The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that it has appointed Jason Hammonds as its new president. Hammonds has […]
Read MoreJune 4, 2021
Over 80 percent of non-small cell lung cancer detected at Stage 4 Fewer than 50 percent of patients had five or more biomarker tests Median time from diagnosis to first-line therapy is about five weeks THE WOODLANDS, TEXAS, June 4, 2021 — Results from the first phase of the broad, collaborative MYLUNG ConsortiumTM research study […]
Read More
